Show simple item record

dc.creatorXenoulis P.G., Moraiti K.T., R. Finco D., Suchodolski J.S., Steiner J.M.en
dc.date.accessioned2023-01-31T11:37:38Z
dc.date.available2023-01-31T11:37:38Z
dc.date.issued2021
dc.identifier10.1111/jvim.16296
dc.identifier.issn08916640
dc.identifier.urihttp://hdl.handle.net/11615/80843
dc.description.abstractBackground: Serum feline pancreatic lipase immunoreactivity (fPLI) and trypsin-like immunoreactivity (fTLI) concentrations are commonly used in cats for the evaluation of pancreatic disease. The effect of kidney disease on these tests in cats are unknown. Objective: To investigate the effect of experimentally induced chronic kidney disease (CKD) on serum fPLI and fTLI concentrations. Animals: Surplus serum samples from 20 cats with CKD experimentally induced for an unrelated project and a group of healthy control cats. Methods: Serum fTLI and fPLI concentrations were compared between groups. Results: Mean (±SD) serum fTLI concentrations in 20 cats with CKD (117.8 ± 63.6 μg/L) were significantly higher than those in healthy cats (n = 32; 46.9 ± 17.5 μg/L; P <.0001). Serum fTLI concentrations in cats with CKD were above the upper limit of the reference interval in 13 of 20 cats (65%). Serum fPLI concentrations were not significantly different between cats with induced CKD (n = 18; 8.6 μg/L; range, 5.4-9.9 μg/L) and healthy cats (n = 41; 7.4 μg/L; range, 5.0-15.2 μg/L; P =.12). All cats with experimentally induced CKD had serum fPLI concentrations within the reference interval. Conclusions and Clinical Importance: Decreased renal function has a clinically relevant impact on serum fTLI concentrations and potentially could interfere with a diagnosis of exocrine pancreatic insufficiency (EPI). Serum fPLI concentration was not affected by experimentally induced CKD and thus serum fPLI may be used for the diagnosis of pancreatitis in cats with kidney disease. Additional studies are needed to verify these results in cats with naturally occurring CKD. © 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.en
dc.language.isoenen
dc.sourceJournal of Veterinary Internal Medicineen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85118474023&doi=10.1111%2fjvim.16296&partnerID=40&md5=23b564907bdfc89d1102a59893e87954
dc.subjectcreatinineen
dc.subjecttriacylglycerol lipaseen
dc.subjecttrypsinen
dc.subjecttriacylglycerol lipaseen
dc.subjecttrypsinen
dc.subjectanimal experimenten
dc.subjectanimal modelen
dc.subjectanimal tissueen
dc.subjectArticleen
dc.subjectcaten
dc.subjectchronic kidney failureen
dc.subjectdisease severityen
dc.subjectexocrine pancreatic insufficiencyen
dc.subjectexperimental chronic renal failureen
dc.subjectfemaleen
dc.subjectimmunoreactivityen
dc.subjectkidney functionen
dc.subjectkidney tumoren
dc.subjectnonhumanen
dc.subjectpancreas diseaseen
dc.subjectprotein blood levelen
dc.subjectreference valueen
dc.subjectsensitivity and specificityen
dc.subjecturinalysisen
dc.subjectanimalen
dc.subjectcaten
dc.subjectcat diseaseen
dc.subjectpancreasen
dc.subjectpancreatitisen
dc.subjectveterinary medicineen
dc.subjectAnimalsen
dc.subjectCat Diseasesen
dc.subjectCatsen
dc.subjectLipaseen
dc.subjectPancreasen
dc.subjectPancreatitisen
dc.subjectRenal Insufficiency, Chronicen
dc.subjectTrypsinen
dc.subjectJohn Wiley and Sons Incen
dc.titleSerum feline pancreatic lipase immunoreactivity and trypsin-like immunoreactivity concentrations in cats with experimentally induced chronic kidney diseaseen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record